• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对新冠病毒的免疫力:……的潜在作用

Immunity against COVID-19: Potential role of .

作者信息

Gautam Shankar, Gautam Arun, Chhetri Sahanshila, Bhattarai Urza

机构信息

Ministry of Health and Population, Kathmandu, Nepal.

Ministry of Social Development, Gandaki Province, Nepal.

出版信息

J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100350. doi: 10.1016/j.jaim.2020.08.003. Epub 2020 Aug 17.

DOI:10.1016/j.jaim.2020.08.003
PMID:32837101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7430223/
Abstract

SARS-CoV-2 infection associated respiratory disease- COVID-19 has evolved into a pandemic but, being a new form of virus, pathogenesis of disease causation is not fully understood and drugs and vaccines against this virus are still being tested so that no effective drugs or vaccines have been advised by regulatory authority. In this context, the Ministry of AYUSH, Government of India has recommended '' to improve the immunity and combat the infection. Our objective of this literature review is to review the role of immunity in pathogenesis of COVID-19 and role of against the virus and regulation of immunity. Current review was conducted using a search of available literature on COVID-19 and immunity, , Ayurveda and COVID-19, , Coronavirus, SARS-CoV-2, immunomodulatory effects of medicinal plants; /Holy Basil/, /Cinnamon/, /Ginger/ and /Black Pepper/. Ayurveda, being an ancient science have both medicinal and cultural values and had stimulated our kitchen and influenced what we ate in different seasons and the remedies we used for common ailments. Herbs such as are the most commonly used and easily available drugs in home. Thus, due to its immune-modulatory, antiviral, anti-oxidant, anti-inflammatory, anti-platelet, anti-atherosclerotic, hepato-protective, reno-protective properties; seems to be effective in immuno-regulation for controlling viral infections like COVID-19. Further pre-clinical and clinical trials need to be done for the evaluation of safety and efficacy of this polyherbal formulation.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染相关的呼吸道疾病——新冠肺炎已演变成一场大流行,但作为一种新型病毒,其致病机制尚未完全明确,针对该病毒的药物和疫苗仍在试验中,因此监管机构尚未推荐有效的药物或疫苗。在此背景下,印度政府阿育吠陀部建议“增强免疫力以对抗感染”。我们进行本次文献综述的目的是回顾免疫力在新冠肺炎发病机制中的作用、对抗该病毒的作用以及免疫调节作用。本次综述通过检索关于新冠肺炎与免疫力、阿育吠陀与新冠肺炎、冠状病毒、SARS-CoV-2、药用植物的免疫调节作用;/圣罗勒/、/肉桂/、/生姜/和/黑胡椒/等方面的现有文献来进行。阿育吠陀作为一门古老的科学,兼具医学和文化价值,它激发了我们的厨房文化,影响了我们在不同季节的饮食以及我们用于治疗常见疾病的疗法。像[此处原文缺失植物名称]这样的草药是家中最常用且容易获取的药物。因此,[此处原文缺失植物名称]由于其免疫调节、抗病毒、抗氧化、抗炎、抗血小板、抗动脉粥样硬化、肝脏保护、肾脏保护特性;似乎在免疫调节以控制像新冠肺炎这样的病毒感染方面是有效的。需要进一步开展临床前和临床试验来评估这种多草药配方的安全性和有效性。

相似文献

1
Immunity against COVID-19: Potential role of .针对新冠病毒的免疫力:……的潜在作用
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100350. doi: 10.1016/j.jaim.2020.08.003. Epub 2020 Aug 17.
2
Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19.阿育吠陀推荐的抗新冠病毒增强免疫力药用植物的网络药理学
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100374. doi: 10.1016/j.jaim.2020.11.004. Epub 2020 Nov 25.
3
AYUSH- 64: A potential therapeutic agent in COVID-19.阿育吠陀-64:一种治疗新冠肺炎的潜在药物。
J Ayurveda Integr Med. 2022 Apr-Jun;13(2):100538. doi: 10.1016/j.jaim.2021.100538. Epub 2022 Jan 4.
4
Indian Medicinal Plants and Formulations and Their Potential Against COVID-19-Preclinical and Clinical Research.印度药用植物与制剂及其抗COVID-19的潜力——临床前和临床研究
Front Pharmacol. 2021 Mar 2;11:578970. doi: 10.3389/fphar.2020.578970. eCollection 2020.
5
Therapeutic and palliative role of a Unani herbal decoction in COVID-19 and similar respiratory viral illnesses: Phytochemical & pharmacological perspective.在 COVID-19 和类似呼吸道病毒疾病中的顺势疗法草药汤剂的治疗和姑息作用:植物化学和药理学观点。
J Ethnopharmacol. 2022 Oct 28;297:115526. doi: 10.1016/j.jep.2022.115526. Epub 2022 Jul 14.
6
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - (Ashwagandha), (Giloy) and (Tulsi) - a molecular docking study.通过阿育吠陀药用植物( Ashwagandha )、( Giloy )和( Tulsi )的活性植物化学成分靶向 COVID-19 ( SARS-CoV-2 )主蛋白酶 - ( Ashwagandha )、( Giloy )和( Tulsi ) - 分子对接研究。
J Biomol Struct Dyn. 2022 Jan;40(1):190-203. doi: 10.1080/07391102.2020.1810778. Epub 2020 Aug 27.
7
Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review.有前景的印度传统药用植物可用于治疗新型冠状病毒病:系统综述。
Phytother Res. 2021 Aug;35(8):4456-4484. doi: 10.1002/ptr.7150. Epub 2021 Jun 16.
8
Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19.阿育吠陀拉沙那作为抗病毒和免疫调节剂:在 COVID-19 中的潜在应用。
Environ Sci Pollut Res Int. 2021 Oct;28(40):55925-55951. doi: 10.1007/s11356-021-16280-5. Epub 2021 Sep 7.
9
Government policies and initiatives for development of Ayurveda.政府发展阿育吠陀的政策和举措。
J Ethnopharmacol. 2017 Feb 2;197:25-31. doi: 10.1016/j.jep.2016.08.018. Epub 2016 Aug 16.
10
evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease.评估阿育吠陀药物AYUSH-64的化合物对新型冠状病毒主要蛋白酶的作用。
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100413. doi: 10.1016/j.jaim.2021.02.004. Epub 2021 Feb 25.

引用本文的文献

1
Integrated Phytochemical Profiling, UPLC-HRMS Characterization, and Bioactivity Evaluation of and .[具体植物名称1]和[具体植物名称2]的综合植物化学分析、超高效液相色谱-高分辨质谱表征及生物活性评价
Int J Mol Sci. 2025 Aug 12;26(16):7782. doi: 10.3390/ijms26167782.
2
Management of Patients With COVID-19 During the Pandemic: A Retrospective Cohort Study From a Tertiary Care Centre in Mumbai, India.疫情期间新冠病毒病患者的管理:来自印度孟买一家三级医疗中心的回顾性队列研究
Cureus. 2025 May 8;17(5):e83711. doi: 10.7759/cureus.83711. eCollection 2025 May.
3
Ethnomedicinal Survey of Plants Used for Treatment of Mild COVID-19-Related Symptoms in Gorontalo Province, Indonesia.印度尼西亚哥伦打洛省用于治疗轻度新冠肺炎相关症状的植物民族药用调查
Scientifica (Cairo). 2025 Apr 21;2025:5849854. doi: 10.1155/sci5/5849854. eCollection 2025.
4
In silico exploration of phytocompounds from AYUSH-64 medicinal plants against SARS CoV-2 RNA-dependent RNA polymerase.对阿育吠陀-64药用植物中的植物化合物针对严重急性呼吸综合征冠状病毒2的RNA依赖性RNA聚合酶进行计算机模拟研究。
J Ayurveda Integr Med. 2024 Nov-Dec;15(6):101026. doi: 10.1016/j.jaim.2024.101026. Epub 2024 Nov 1.
5
Utilization of Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homoeopathy (AYUSH) Practitioners' Services Among Older Adults: Results From the Longitudinal Aging Study in India.印度老年人对阿育吠陀、瑜伽、自然疗法、尤那尼、悉达和顺势疗法(阿育吠陀等传统医学体系)从业者服务的利用情况:来自印度纵向老龄化研究的结果
Cureus. 2024 Jun 11;16(6):e62192. doi: 10.7759/cureus.62192. eCollection 2024 Jun.
6
Plant-Derived Natural Compounds as an Emerging Antiviral in Combating COVID-19.植物源天然化合物作为对抗 COVID-19 的新型抗病毒药物
Indian J Microbiol. 2023 Dec;63(4):429-446. doi: 10.1007/s12088-023-01121-5. Epub 2023 Oct 31.
7
Stability of psychological wellbeing during the COVID-19 pandemic among people with an anthroposophical worldview: the influence of wondering awe and perception of nature as resources.新冠疫情期间具有人智学世界观人群心理健康的稳定性:好奇敬畏感和将自然视为资源的感知的影响。
Front Public Health. 2023 Jul 21;11:1200067. doi: 10.3389/fpubh.2023.1200067. eCollection 2023.
8
Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now.对抗细胞因子风暴和免疫调节缺陷:截至目前采用天然产物疗法。
Front Pharmacol. 2023 Apr 12;14:1111329. doi: 10.3389/fphar.2023.1111329. eCollection 2023.
9
Natural Products as a Potential Source of Promising Therapeutics for COVID-19 and Viral Diseases.天然产物作为治疗新冠肺炎及病毒性疾病的潜在有效药物来源
Evid Based Complement Alternat Med. 2023 Apr 15;2023:5525165. doi: 10.1155/2023/5525165. eCollection 2023.
10
Plant Extracts and SARS-CoV-2: Research and Applications.植物提取物与新型冠状病毒:研究与应用
Life (Basel). 2023 Jan 31;13(2):386. doi: 10.3390/life13020386.

本文引用的文献

1
Immunity-Boosting Spices and the Novel Coronavirus.增强免疫力的香料与新型冠状病毒。
ACS Chem Neurosci. 2020 Jun 17;11(12):1696-1698. doi: 10.1021/acschemneuro.0c00239. Epub 2020 May 26.
2
Ayurveda and COVID-19: Where psychoneuroimmunology and the meaning response meet.阿育吠陀与 COVID-19:心理神经免疫学与意义反应相遇之处。
Brain Behav Immun. 2020 Jul;87:8-9. doi: 10.1016/j.bbi.2020.04.056. Epub 2020 Apr 22.
3
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
4
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.严重 COVID-19 中的细胞因子释放综合征:白细胞介素-6 受体拮抗剂托珠单抗可能是降低死亡率的关键。
Int J Antimicrob Agents. 2020 May;55(5):105954. doi: 10.1016/j.ijantimicag.2020.105954. Epub 2020 Mar 29.
5
Virology, Epidemiology, Pathogenesis, and Control of COVID-19.COVID-19 的病毒学、流行病学、发病机制和防控。
Viruses. 2020 Mar 27;12(4):372. doi: 10.3390/v12040372.
6
COVID-19 infection: the perspectives on immune responses.新型冠状病毒肺炎感染:免疫反应的观点
Cell Death Differ. 2020 May;27(5):1451-1454. doi: 10.1038/s41418-020-0530-3. Epub 2020 Mar 23.
7
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病:考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
8
COVID-19 in Children: Initial Characterization of the Pediatric Disease.儿童新型冠状病毒肺炎:儿科疾病的初步特征
Pediatrics. 2020 Jun;145(6). doi: 10.1542/peds.2020-0834. Epub 2020 Mar 16.
9
Calcio-herbal formulation, Divya-Swasari-Ras, alleviates chronic inflammation and suppresses airway remodelling in mouse model of allergic asthma by modulating pro-inflammatory cytokine response.草药配方迪维亚斯瓦萨里乳霜通过调节促炎细胞因子反应缓解过敏性哮喘小鼠模型的慢性炎症和抑制气道重塑。
Biomed Pharmacother. 2020 Jun;126:110063. doi: 10.1016/j.biopha.2020.110063. Epub 2020 Mar 4.
10
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.2019-nCoV 对口腔黏膜上皮细胞 ACE2 受体的高表达。
Int J Oral Sci. 2020 Feb 24;12(1):8. doi: 10.1038/s41368-020-0074-x.